Summary
Updated Aug 31, 2026
Elisabeth Leiderman is Director of Autolus Therapeutics plc (AUTL). 3 SEC Form 4 filings on record going back to 2024, most recently on 1 July 2026.
Recent Transactions
3Every recent SEC Form 4 transaction Elisabeth Leiderman has reported, most recent first.
Most Active Insiders Right Now
Elisabeth Leiderman has no co-filers on record, so these are insiders with the largest open-market activity across the market in the last 90 days.
- Ronald Clarke - $88.51M of CPAY open-market activity in the last 90 days
- Yousif Mohammed Ali Nasser Al-Nowais - $88.47M of NESR open-market activity in the last 90 days
- Thomas J. Nimbley - $87.92M of PBF open-market activity in the last 90 days
- John Colgrove - $87.13M of P open-market activity in the last 90 days
- David Zaslav - $86.59M of WBD open-market activity in the last 90 days
- VisionWave Holdings, Inc. - $7.98B of SVRE open-market activity in the last 90 days
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Elisabeth Leiderman?
Elisabeth Leiderman is a corporate insider, tracked as Director of Autolus Therapeutics plc (AUTL). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Elisabeth Leiderman submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Elisabeth Leiderman's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Elisabeth Leiderman and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
